CAPSYD'S PLAN

For phages to be a viable therapeutic option, they need to be able to target a broad range of bacterial strains and they need to kill them immediately so bacteria won't stand a chance. Unfortunately, effective C-Diff phages with both these qualities are hard to find in nature.

However, Capsyd's revolutionary tail-diversifying technology, combined with state-of-the-art machine learning-based approaches, enable us to engineer a diverse pool of closely-related phages that will target the most deadly strains of C-Diff.. and we do it with unparalleled cost-efficiency.